The Seventies and Eighties brought a new dawn in many areas. Once Michael Reckeweg entered the company in 1976 and the company moved into the new building with more than 2,000 Sqm. in 1981 and thus having to hire more personnel, the turning point for a redirection of the family business to a pharmaceutical company was completed. From that time on the main interest was to open markets abroad.
Dr. Reckeweg established business contacts to importers in European and non-European countries pushing international expansion. Today Dr. Reckeweg maintains intensive contacts to importers in over 40 countries in Europe and all over the world. The export share of more than 90% documents impressively the high acceptance and appreciation of Dr. Reckeweg’s homeopathic remedies. Along with regional and global expansion of business came an internal expansion of the portfolio. The line of specialties was expanded to 75 and later to 95 remedies, offering some of the specialties in different forms such as dilutions, injectables, globules, tablets, ointments, and syrups. In addition to those specialties, the company produced and distributed mother tinctures, single remedies in high and highest potencies, salts of the biochemical healing method according to Dr. Schüßler and homeopathic preparations for veterinary medicine along with some food supplements which completed the product range in the Eighties and Nineties. In addition, the company started working on development and distribution of an electro-acupuncture device.
All this took place during the change of generations from the company’s founders to the current Managing Director Michael Reckeweg. At the same time the reorganization of responsibilities in accordance with legal requirements for a pharmaceutical company was established, one of them being the requirement to manufacture according to the international guidelines GMP (Good Manufacturing Practice). Since 1999 the company is – as one of the co-founders – an active member of ECHAMP (abbrev. European Coalition on Homeopathic and Anthroposophic Medicinal Products).
Remarkable as well is the membership in the ’Bundesverband der Pharmazeutischen Industrie (BPI, federal association of the pharmaceutical industry)’ as well as in the ’Bundesverband der Arzneimittelhersteller (BAH, federal association of drug manufacturers)’. In both, the company is engaged in active cooperation in various committees and panels representing the interests of homeopathy.